Research Paper Volume 16, Issue 9 pp 8000—8018
A systematic pan-cancer analysis identifies LDHA as a novel predictor for immunological, prognostic, and immunotherapy resistance
Figure 9. Analysis of LDHA genetic alterations in different types of cancers. (A) The frequency of LDHA mutations with mutation type across TCGA cancers by cBioPortal. (B) Oncoprint of LDHA gene alterations in cancer cohorts. (C) Mutation sites of the LDHA in TCGA samples. (D–G) The associations of pan-cancer LDHA mutation status with OS, DSS, DFS and PFS by cBioPortal. (H) The association of LDHA expression with TMB in pan-cancer. (I) The association of LDHA expression with MSI in pan-cancer.